287 related articles for article (PubMed ID: 12428575)
21. Matrix metalloproteinases in cancer: comparison of known and novel aspects of their inhibition as a therapeutic approach.
Bachmeier BE; Iancu CM; Jochum M; Nerlich AG
Expert Rev Anticancer Ther; 2005 Feb; 5(1):149-63. PubMed ID: 15757447
[TBL] [Abstract][Full Text] [Related]
22. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair.
Gabison EE; Hoang-Xuan T; Mauviel A; Menashi S
Biochimie; 2005; 87(3-4):361-8. PubMed ID: 15781323
[TBL] [Abstract][Full Text] [Related]
23. Mitochondrial redox control of matrix metalloproteinases.
Nelson KK; Melendez JA
Free Radic Biol Med; 2004 Sep; 37(6):768-84. PubMed ID: 15304253
[TBL] [Abstract][Full Text] [Related]
24. Peripheral blood levels of matrix metalloproteinases in patients referred for percutaneous balloon mitral valve commissurotomy.
Garr RJ; Krasuski RA; Eckart RE; Wang A; Pierce C; Kisslo KB; Harrison JK; Bashore TM
J Heart Valve Dis; 2006 May; 15(3):369-74. PubMed ID: 16784074
[TBL] [Abstract][Full Text] [Related]
25. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.
Spinale FG
Physiol Rev; 2007 Oct; 87(4):1285-342. PubMed ID: 17928585
[TBL] [Abstract][Full Text] [Related]
26. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation.
Van Lint P; Libert C
J Leukoc Biol; 2007 Dec; 82(6):1375-81. PubMed ID: 17709402
[TBL] [Abstract][Full Text] [Related]
27. New implications of the proteolytic balance between matrix metalloproteinases and their tissue inhibitors in migraine with and without aura.
Mannello F
Clin Chim Acta; 2009 Nov; 409(1-2):1-3. PubMed ID: 19632213
[TBL] [Abstract][Full Text] [Related]
28. Structure and function of matrix metalloproteinases and TIMPs.
Nagase H; Visse R; Murphy G
Cardiovasc Res; 2006 Feb; 69(3):562-73. PubMed ID: 16405877
[TBL] [Abstract][Full Text] [Related]
29. [The role of metalloproteinases in kidney pathophysiology].
Rysz J; Pedzik A; Markuszewski L; Kujawski K; Błaszczak R; Olszewski R
Pol Merkur Lekarski; 2005 Dec; 19(114):812-5. PubMed ID: 16521430
[TBL] [Abstract][Full Text] [Related]
30. [Matrix metalloproteinases in the central nervous system: clinical significance and therapeutic prospects].
Sulik A; Ołdak E
Pol Merkur Lekarski; 2008 Mar; 24(141):278-80. PubMed ID: 18634301
[TBL] [Abstract][Full Text] [Related]
31. [Matrix metalloproteinases and their tissue inhibitors in malignancies of the female genital tract].
Piura B; Rabinovich A; Huleihel M
Harefuah; 2003 Nov; 142(11):786-91, 804. PubMed ID: 14631913
[TBL] [Abstract][Full Text] [Related]
32. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors.
Fondard O; Detaint D; Iung B; Choqueux C; Adle-Biassette H; Jarraya M; Hvass U; Couetil JP; Henin D; Michel JB; Vahanian A; Jacob MP
Eur Heart J; 2005 Jul; 26(13):1333-41. PubMed ID: 15827062
[TBL] [Abstract][Full Text] [Related]
33. Vascular remodeling and protease inhibition--bench to bedside.
Sluijter JP; de Kleijn DP; Pasterkamp G
Cardiovasc Res; 2006 Feb; 69(3):595-603. PubMed ID: 16387286
[TBL] [Abstract][Full Text] [Related]
34. What role do extracellular matrix changes contribute to the cardiovascular disease burden of diabetes mellitus?
Tayebjee MH; Lip GY; MacFadyen RJ
Diabet Med; 2005 Dec; 22(12):1628-35. PubMed ID: 16401304
[TBL] [Abstract][Full Text] [Related]
35. [The role of matrix metalloproteinases in venous leg ulcers development].
Bogaczewicz J; Dudek W; Wroński J; Chodorowska G; Przywara S; Krasowska D; Zubilewicz T
Pol Merkur Lekarski; 2005 Nov; 19(113):686-92. PubMed ID: 16498813
[TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies.
Folgueras AR; Pendás AM; Sánchez LM; López-Otín C
Int J Dev Biol; 2004; 48(5-6):411-24. PubMed ID: 15349816
[TBL] [Abstract][Full Text] [Related]
37. Biology of metalloproteinases.
Amălinei C; Căruntu ID; Bălan RA
Rom J Morphol Embryol; 2007; 48(4):323-34. PubMed ID: 18060181
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
Visse R; Nagase H
Circ Res; 2003 May; 92(8):827-39. PubMed ID: 12730128
[TBL] [Abstract][Full Text] [Related]
39. New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression.
Leeman MF; Curran S; Murray GI
J Pathol; 2003 Dec; 201(4):528-34. PubMed ID: 14648655
[TBL] [Abstract][Full Text] [Related]
40. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model.
Karagiannis ED; Popel AS
J Theor Biol; 2006 Jan; 238(1):124-45. PubMed ID: 16005020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
